IP Library Granted Patent US 10,217,620
Granted Patent B2
US 10,217,620 · App. 16/020,183 · Granted Feb 26, 2019

Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF mass spectrometry

Inventors: Joanna Röder (Steamboat Springs, CO); Carlos Oliveira (Steamboat Springs, CO); Julia Grigorieva (Steamboat Springs, CO); Heinrich Röder (Steamboat Springs, CO); Devalingam Mahalingam (San Antonio, TX)
Assignee: Biodesix, Inc.
H01J49/0036G01N33/57438G01N33/6851G06K9/00147G06K9/6228G06K9/6276G16H10/40G16H50/70H01J49/164G06K9/00536Y02A90/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,217,620
App. No.
16/020,183
Granted
Feb 26, 2019
Kind
B2
Abstract

Hepatocellular carcinoma (HCC) is detected in a patient with liver disease. Mass spectrometry data from a blood-based sample from the patient is compared to a reference set of mass-spectrometry data from a multitude of other patients with liver disease, including patients with and without HCC, in a general purpose computer configured as a classifier. The classifier generates a class label, such as HCC or No HCC, for the test sample. A laboratory system for early detection of HCC in patients with liver disease is also disclosed. Alternative testing strategies using AFP measurement and a reference set for classification in the form of class-labeled mass spectral data from blood-based samples of lung cancer patients are also described, including multi-stage testing.

Claims (14)

1. A method of detecting a class label in a liver disease patient comprising:

a) conducting mass spectrometry on a blood-based sample of the patient and obtaining mass spectrometry data;

(b) obtaining integrated intensity values in the mass spectral data of a multitude of pre-determined mass-spectral features; and

(c) operating on the mass spectral data with a programmed computer implementing a classifier;

wherein in the operating step the classifier compares the integrated intensity values with feature values of a training set of class-labeled mass spectral data obtained from a multitude of other patients with liver disease with the values obtained in step (b) with a classification algorithm and detects a class label for the sample.

2. The method of claim 1 , wherein the mass spectrometry comprises performing MALDI-TOF mass spectrometry by subjecting the blood-based sample to at least 100,000 laser shots and acquiring mass spectral data.

3. The method of claim 1 , wherein the classifier is obtained from filtered mini-classifiers combined using a regularized combination method.

4. The method of claim 3 , wherein the mini-classifiers perform classifications using single features, pairs of features, or single features, pairs of features and triplets of features in the feature values of a training set.

5. The method of claim 1 , wherein the obtaining step (b) comprises obtaining integrated intensity values of at least 50 features listed in one of the Appendices.

6. The method of claim 5 , wherein the obtaining step comprises obtaining integrated intensity values of at least 100 features listed in Example 1 Appendix A or Example 2 Appendix C.

7. The method of claim 5 , wherein the obtaining step comprises obtaining integrated intensity values of all the features of one of the Appendices.

8. The method of claim 1 , wherein the training set comprises all or a subset of a set of samples used to develop the classifier.

9. The method of claim 8 , wherein the training set is a subset of the set of samples used to develop the classifier pruned to remove those patients who have high AFP expression levels.

10. The method of claim 1 , wherein the feature values consist of the mass spectral features and AFP expression level.

Assignments (4)
SECURITY AGREEMENT Recorded Nov 22, 2022
From: BIODESIX, INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 061977/0919 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2018
From: MAHALINGAM, DEVALINGAM
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 046923/0578 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2018
From: RODER, JOANNA; OLIVEIRA, CARLOS; GRIGORIEVA, JULIA; RODER, HEINRICH
To: BIODESIX INC.
Reel/Frame 046923/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2018
From: RODER, JOANNA; OLIVEIRA, CARLOS; GRIGORIEVA, JULIA; RODER, HEINRICH
To: BIODESIX INC.
Reel/Frame 046235/0207 →
Continuity (3)
Continuation 14936847 · Nov 10, 2015
Provisional Application 62086805 · Dec 3, 2014
Related Publication 20180323049A1 · Nov 8, 2018
Cited By (2)
US 12,230,398 US 12,546,697